Quantitative phosphoproteomics dissection of 7TM receptor signaling using full and biased agonists

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Quantitative phosphoproteomics dissection of 7TM receptor signaling using full and biased agonists. / Christensen, Gitte Lund; Kelstrup, Christian; Lyngsø, Christina; Sarwar, Uzma; Bøgebo, Rikke; Sheikh, Søren P; Gammeltoft, Steen; Olsen, Jesper V; Hansen, Jakob L.

In: Molecular and Cellular Proteomics, Vol. 9, No. 7, 07.2010, p. 1540-53.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Christensen, GL, Kelstrup, C, Lyngsø, C, Sarwar, U, Bøgebo, R, Sheikh, SP, Gammeltoft, S, Olsen, JV & Hansen, JL 2010, 'Quantitative phosphoproteomics dissection of 7TM receptor signaling using full and biased agonists', Molecular and Cellular Proteomics, vol. 9, no. 7, pp. 1540-53. https://doi.org/10.1074/mcp.M900550-MCP200

APA

Christensen, G. L., Kelstrup, C., Lyngsø, C., Sarwar, U., Bøgebo, R., Sheikh, S. P., Gammeltoft, S., Olsen, J. V., & Hansen, J. L. (2010). Quantitative phosphoproteomics dissection of 7TM receptor signaling using full and biased agonists. Molecular and Cellular Proteomics, 9(7), 1540-53. https://doi.org/10.1074/mcp.M900550-MCP200

Vancouver

Christensen GL, Kelstrup C, Lyngsø C, Sarwar U, Bøgebo R, Sheikh SP et al. Quantitative phosphoproteomics dissection of 7TM receptor signaling using full and biased agonists. Molecular and Cellular Proteomics. 2010 Jul;9(7):1540-53. https://doi.org/10.1074/mcp.M900550-MCP200

Author

Christensen, Gitte Lund ; Kelstrup, Christian ; Lyngsø, Christina ; Sarwar, Uzma ; Bøgebo, Rikke ; Sheikh, Søren P ; Gammeltoft, Steen ; Olsen, Jesper V ; Hansen, Jakob L. / Quantitative phosphoproteomics dissection of 7TM receptor signaling using full and biased agonists. In: Molecular and Cellular Proteomics. 2010 ; Vol. 9, No. 7. pp. 1540-53.

Bibtex

@article{afe01970456f11df928f000ea68e967b,
title = "Quantitative phosphoproteomics dissection of 7TM receptor signaling using full and biased agonists",
abstract = "Seven-transmembrane receptors (7TMRs) signal through the well described heterotrimeric G proteins, but can also activate G protein-independent signaling pathways of which the impact and complexity are less understood. The Angiotensin II type 1 receptor (AT1R) is a prototypical 7TMR and an important drug target in cardiovascular diseases. {"}Biased agonists{"}, with intrinsic {"}functional selectivity{"}, that simultaneously blocks Gaq protein activity, and activitates G protein independent pathways of the AT1R, confer important perspectives in treatment of cardiovascular diseases.n this study we performed a global quantitative phosphoproteomics analysis of the AT1R signaling network. We analyzed ligand-stimulated SILAC cells by high-resolution mass spectrometry (LTQ Orbitrap MS) and compared the phosphoproteomes of the AT1R agonist Angiotensin II and the biased agonist SII Angiotensin II, which only activates the Gaq protein-independent signaling.e quantified more than ten thousand phosphorylation sites of which 1183 were regulated by Angiotensin II or its analogue SII Angiotensin II. 36% of the AT1R regulated phosphorylations were regulated by SII Angiotensin II. Analysis of phosphorylation site patterns displays a striking distinction between protein kinases activated by Gaq protein-dependent and -independent mechanisms, and we now place protein kinase D as a key protein involved in both Gaq-dependent and independent AT1R signaling.his study provides substantial novel insight into Angiotensin II signal transduction and is the first study dissecting the differences between a full agonist and a biased agonist from a 7TMR on a systems-wide scale. Importantly, it reveals a previously unappreciated diversity and quantity of Gaq protein-independent signaling and uncovers novel signaling pathways. We foresee that the amount and diversity of G protein independent signaling may be more pronounced than previously recognized for other 7TMRs as well. Quantitative mass spectrometry is a promising tool for evaluation of the signaling properties of biased agonists to other receptors in the future.",
author = "Christensen, {Gitte Lund} and Christian Kelstrup and Christina Lyngs{\o} and Uzma Sarwar and Rikke B{\o}gebo and Sheikh, {S{\o}ren P} and Steen Gammeltoft and Olsen, {Jesper V} and Hansen, {Jakob L}",
year = "2010",
month = jul,
doi = "10.1074/mcp.M900550-MCP200",
language = "English",
volume = "9",
pages = "1540--53",
journal = "Molecular and Cellular Proteomics",
issn = "1535-9476",
publisher = "American Society for Biochemistry and Molecular Biology",
number = "7",

}

RIS

TY - JOUR

T1 - Quantitative phosphoproteomics dissection of 7TM receptor signaling using full and biased agonists

AU - Christensen, Gitte Lund

AU - Kelstrup, Christian

AU - Lyngsø, Christina

AU - Sarwar, Uzma

AU - Bøgebo, Rikke

AU - Sheikh, Søren P

AU - Gammeltoft, Steen

AU - Olsen, Jesper V

AU - Hansen, Jakob L

PY - 2010/7

Y1 - 2010/7

N2 - Seven-transmembrane receptors (7TMRs) signal through the well described heterotrimeric G proteins, but can also activate G protein-independent signaling pathways of which the impact and complexity are less understood. The Angiotensin II type 1 receptor (AT1R) is a prototypical 7TMR and an important drug target in cardiovascular diseases. "Biased agonists", with intrinsic "functional selectivity", that simultaneously blocks Gaq protein activity, and activitates G protein independent pathways of the AT1R, confer important perspectives in treatment of cardiovascular diseases.n this study we performed a global quantitative phosphoproteomics analysis of the AT1R signaling network. We analyzed ligand-stimulated SILAC cells by high-resolution mass spectrometry (LTQ Orbitrap MS) and compared the phosphoproteomes of the AT1R agonist Angiotensin II and the biased agonist SII Angiotensin II, which only activates the Gaq protein-independent signaling.e quantified more than ten thousand phosphorylation sites of which 1183 were regulated by Angiotensin II or its analogue SII Angiotensin II. 36% of the AT1R regulated phosphorylations were regulated by SII Angiotensin II. Analysis of phosphorylation site patterns displays a striking distinction between protein kinases activated by Gaq protein-dependent and -independent mechanisms, and we now place protein kinase D as a key protein involved in both Gaq-dependent and independent AT1R signaling.his study provides substantial novel insight into Angiotensin II signal transduction and is the first study dissecting the differences between a full agonist and a biased agonist from a 7TMR on a systems-wide scale. Importantly, it reveals a previously unappreciated diversity and quantity of Gaq protein-independent signaling and uncovers novel signaling pathways. We foresee that the amount and diversity of G protein independent signaling may be more pronounced than previously recognized for other 7TMRs as well. Quantitative mass spectrometry is a promising tool for evaluation of the signaling properties of biased agonists to other receptors in the future.

AB - Seven-transmembrane receptors (7TMRs) signal through the well described heterotrimeric G proteins, but can also activate G protein-independent signaling pathways of which the impact and complexity are less understood. The Angiotensin II type 1 receptor (AT1R) is a prototypical 7TMR and an important drug target in cardiovascular diseases. "Biased agonists", with intrinsic "functional selectivity", that simultaneously blocks Gaq protein activity, and activitates G protein independent pathways of the AT1R, confer important perspectives in treatment of cardiovascular diseases.n this study we performed a global quantitative phosphoproteomics analysis of the AT1R signaling network. We analyzed ligand-stimulated SILAC cells by high-resolution mass spectrometry (LTQ Orbitrap MS) and compared the phosphoproteomes of the AT1R agonist Angiotensin II and the biased agonist SII Angiotensin II, which only activates the Gaq protein-independent signaling.e quantified more than ten thousand phosphorylation sites of which 1183 were regulated by Angiotensin II or its analogue SII Angiotensin II. 36% of the AT1R regulated phosphorylations were regulated by SII Angiotensin II. Analysis of phosphorylation site patterns displays a striking distinction between protein kinases activated by Gaq protein-dependent and -independent mechanisms, and we now place protein kinase D as a key protein involved in both Gaq-dependent and independent AT1R signaling.his study provides substantial novel insight into Angiotensin II signal transduction and is the first study dissecting the differences between a full agonist and a biased agonist from a 7TMR on a systems-wide scale. Importantly, it reveals a previously unappreciated diversity and quantity of Gaq protein-independent signaling and uncovers novel signaling pathways. We foresee that the amount and diversity of G protein independent signaling may be more pronounced than previously recognized for other 7TMRs as well. Quantitative mass spectrometry is a promising tool for evaluation of the signaling properties of biased agonists to other receptors in the future.

U2 - 10.1074/mcp.M900550-MCP200

DO - 10.1074/mcp.M900550-MCP200

M3 - Journal article

C2 - 20363803

VL - 9

SP - 1540

EP - 1553

JO - Molecular and Cellular Proteomics

JF - Molecular and Cellular Proteomics

SN - 1535-9476

IS - 7

ER -

ID: 19160354